Boerbok Ltd 10627069 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 10627069 2023-03-01 2024-02-29 10627069 2024-02-29 10627069 core:RetainedEarningsAccumulatedLosses 2024-02-29 10627069 core:ShareCapital 2024-02-29 10627069 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 10627069 bus:SmallEntities 2023-03-01 2024-02-29 10627069 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 10627069 bus:FullAccounts 2023-03-01 2024-02-29 10627069 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 10627069 bus:RegisteredOffice 2023-03-01 2024-02-29 10627069 bus:Director2 2023-03-01 2024-02-29 10627069 bus:Director3 2023-03-01 2024-02-29 10627069 bus:Director3 1 2023-03-01 2024-02-29 10627069 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 10627069 core:Goodwill 2023-03-01 2024-02-29 10627069 core:LeaseholdImprovements 2023-03-01 2024-02-29 10627069 core:OfficeEquipment 2023-03-01 2024-02-29 10627069 core:PlantMachinery 2023-03-01 2024-02-29 10627069 countries:AllCountries 2023-03-01 2024-02-29 10627069 2023-02-28 10627069 2022-03-01 2023-02-28 10627069 2023-02-28 10627069 core:RetainedEarningsAccumulatedLosses 2023-02-28 10627069 core:ShareCapital 2023-02-28 10627069 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 10627069

Boerbok Ltd

trading as Uxbridge Vets

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 29 February 2024

 

Boerbok Ltd

trading as Uxbridge Vets

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

Boerbok Ltd

trading as Uxbridge Vets

(Registration number: 10627069)
Abridged Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

85,868

100,345

Tangible assets

5

143,965

139,146

 

229,833

239,491

Current assets

 

Stocks

42,210

11,274

Debtors

20,303

58,205

Cash at bank and in hand

 

64,384

124,652

 

126,897

194,131

Creditors: Amounts falling due within one year

(132,696)

(201,778)

Net current liabilities

 

(5,799)

(7,647)

Total assets less current liabilities

 

224,034

231,844

Provisions for liabilities

(23,268)

(22,903)

Net assets

 

200,766

208,941

Capital and reserves

 

Called up share capital

150

150

Profit and loss account

200,616

208,791

Total equity

 

200,766

208,941

 

Boerbok Ltd

trading as Uxbridge Vets

(Registration number: 10627069)
Abridged Balance Sheet as at 29 February 2024

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 26 November 2024 and signed on its behalf by:
 

Mr AJ Townsend

Director

Mr M Vince

Director

 

Boerbok Ltd

trading as Uxbridge Vets

Notes to the Unaudited Abridged Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
65 Belmont Road
Uxbridge
Greater London
UB8 1QT
England

These financial statements were authorised for issue by the Board on 26 November 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis. Of the company's current liabilities at 29 February 2024, an amount is owed to the directors, who have agreed to continue to support the company, and not to demand repayment of the amount to the extent that any such repayment would jeopardise the future of the company.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

Boerbok Ltd

trading as Uxbridge Vets

Notes to the Unaudited Abridged Financial Statements for the Year Ended 29 February 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

20% Reducing balance

Plant and machinery

15% Reducing balance

Leasehold improvements

Across term of the lease

Goodwill

Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

10% Straight line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 14 (2023 - 11).

4

Intangible assets

Total
£

Cost or valuation

At 1 March 2023

144,767

At 29 February 2024

144,767

Amortisation

At 1 March 2023

44,422

Amortisation charge

14,477

At 29 February 2024

58,899

Carrying amount

At 29 February 2024

85,868

At 28 February 2023

100,345

 

Boerbok Ltd

trading as Uxbridge Vets

Notes to the Unaudited Abridged Financial Statements for the Year Ended 29 February 2024

5

Tangible assets

Total
£

Cost or valuation

At 1 March 2023

198,917

Additions

32,503

At 29 February 2024

231,420

Depreciation

At 1 March 2023

59,771

Charge for the year

27,684

At 29 February 2024

87,455

Carrying amount

At 29 February 2024

143,965

At 28 February 2023

139,146

6

Related party transactions

Advances to directors


Mr M Vince

During the period Mr M Vince went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £21,652 (2023 - £Nil). At the year end the amount outstanding from Mr M Vince was £19,255 (2023 - £-). Interest has been charged at the commercial rate.